Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Florence Wong

Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

About

Professor Florence Wong is a faculty member at the University of Toronto, Canada. Her research focuses on liver disease, particularly in relation to patient-reported outcomes, ascites management, and acute kidney injury in cirrhosis. Recent publications include studies on the impacts of various treatments in liver conditions and systematic reviews assessing mortality and organ dysfunction in patients with liver disease.

Articles (24)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Hugo E. Vargas

Consultant/Professor of Medicine

Mayo Clinic Arizona

UNITED STATES

View details

Leroy Thacker

Associate Professor

Virginia Commonwealth University

UNITED STATES

View details

Constantine Karvellas

Professor

University of Alberta

CANADA

View details

Arun Sanyal

Professor of Medicine

Virginia Commonwealth University

UNITED STATES

View details

Amany Zekry

Director

AUSTRALIA

View details

Pere Ginès

University of Barcelona

SPAIN

View details

Jacob George

Professor

University of Sydney

AUSTRALIA

View details

Puneeta Tandon

University of Alberta

CANADA

View details

Jennifer Lai

University of California, San Francisco

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Florence Wong

Research Interests

Explore related searches

About

Articles (24)

Comparison of Factors Associated With 30-Day and 90-Day Readmission Among a Global Cohort of Patients Hospitalised With Cirrhosis

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective

Albumin in the Management of Hepatorenal Syndrome–Acute Kidney Injury: Is There Ever Too Much?

Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort

Sex Differences in Patient-Reported Outcomes and Perception of Ascites Burden Among Outpatients With Decompensated Cirrhosis and Ascites

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies

Preascitic Sodium Retention in Cirrhosis: A Role for Disregulated Proteolysis by Proprotein Convertases?

Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings

The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory Ascites

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis

Innovative Management of a Difficult Case of Hepatic Hydrothorax

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis

Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin

Hepatorenal syndrome: Updates

Innovative approaches to the management of ascites in cirrhosis

Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know

Organ dysfunction and failure in liver disease

Let's Have Some Clarity on Academic Parity

Management of refractory ascites

Editorial: terlipressin in patients with ACLF grade 3—too late? Authorsʼ reply

AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis

Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis

Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure

The Cardiorenal Connection: Is Cardiac Output the Sole Determinant of Renal Dysfunction in Cirrhosis?

Collaborators (9)

Hugo E. Vargas

Leroy Thacker

Constantine Karvellas

Arun Sanyal

Amany Zekry

Pere Ginès

Jacob George

Puneeta Tandon

Jennifer Lai

Make your next move.